Literature DB >> 12532331

The E2F-1 transcription factor is negatively regulated by its interaction with the MDMX protein.

Gordon D Strachan1, Kelly L Jordan-Sciutto, Ravikumar Rallapalli, Rocky S Tuan, David J Hall.   

Abstract

Several proteins with important roles in oncogenesis have been shown to regulate the function of the E2F-1 transcription factor, which is known to activate the expression of genes required for proliferation and apoptosis. Here we identify the MDMX oncoprotein as an E2F-1-binding factor, from a yeast-two hybrid screen using a portion of the E2F-1 protein as "bait." We demonstrate that the region within MDMX needed for the E2F-1:MDMX interaction is located in the central part of the protein, C-terminal of the p53-binding domain. The region within E2F-1 needed for this association is adjacent to the DNA binding domain. Further, when expressed in vivo or in vitro the MDMX protein migrates as two isoforms on SDS-PAGE, the faster migrating isoform having the stronger affinity for the E2F-1 proteins. It appears that this interaction reduces the ability of E2F-1 to bind DNA. Expression of MDMX along with E2F-1 and Dp-1 in Saos2 cells reduces the ability of E2F-1 to bind to its consensus DNA sequence, without altering E2F-1 protein levels. These data indicate that the MDMX protein is capable of associating with E2F-1 and negatively regulating its DNA binding ability. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532331     DOI: 10.1002/jcb.10318

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage.

Authors:  Daniel J Colacurcio; Alyssa Yeager; Dennis L Kolson; Kelly L Jordan-Sciutto; Cagla Akay
Journal:  Mol Cell Neurosci       Date:  2013-10-12       Impact factor: 4.314

2.  Mdm4 supports DNA replication in a p53-independent fashion.

Authors:  Kai Wohlberedt; Ina Klusmann; Polina K Derevyanko; Kester Henningsen; Josephine Ann Mun Yee Choo; Valentina Manzini; Anna Magerhans; Celeste Giansanti; Christine M Eischen; Aart G Jochemsen; Matthias Dobbelstein
Journal:  Oncogene       Date:  2020-05-19       Impact factor: 9.867

3.  MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.

Authors:  Alyssa M Klein; Lynn Biderman; David Tong; Bita Alaghebandan; Sakina A Plumber; Helen S Mueller; Anne van Vlimmeren; Chen Katz; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-02       Impact factor: 11.205

Review 4.  MdmX regulates transformation and chromosomal stability in p53-deficient cells.

Authors:  Zdenka Matijasevic; Anna Krzywicka-Racka; Greenfield Sluder; Stephen N Jones
Journal:  Cell Cycle       Date:  2008-10-15       Impact factor: 4.534

Review 5.  Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy.

Authors:  Qin Li; Guillermina Lozano
Journal:  Clin Cancer Res       Date:  2012-12-21       Impact factor: 12.531

6.  Recurrent genetic alterations in hepatitis C-associated hepatocellular carcinoma detected by genomic microarray: a genetic, clinical and pathological correlation study.

Authors:  Yajuan J Liu; Yang Zhou; Matthew M Yeh
Journal:  Mol Cytogenet       Date:  2014-11-25       Impact factor: 2.009

Review 7.  Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB.

Authors:  Jesús Hernández-Monge; Adriana Berenice Rousset-Roman; Ixaura Medina-Medina; Vanesa Olivares-Illana
Journal:  Genes Cancer       Date:  2016-09

Review 8.  To live or let die - complexity within the E2F1 pathway.

Authors:  A Poppy Roworth; Fatemeh Ghari; Nicholas B La Thangue
Journal:  Mol Cell Oncol       Date:  2015-01-30

Review 9.  SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes.

Authors:  Yogita Chhichholiya; Aman Kumar Suryan; Prabhat Suman; Anjana Munshi; Sandeep Singh
Journal:  Front Genet       Date:  2021-12-01       Impact factor: 4.599

10.  MDM4 (MDMX) and its Transcript Variants.

Authors:  F Mancini; G Di Conza; F Moretti
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.